Fidrok Pharmaceuticals Private Limited
About Fidrok Pharmaceuticals Private Limited
Data last updated:
Fidrok Pharmaceuticals Private Limited is a private limited company based in Gmc, Assam, India. It was incorporated on 13 May 2023.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U46497AS2023PTC024621.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Bondita Sarmah and Anannya Chakraborty.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gmc, Assam.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.05 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹77,674 (net margin 1.7%) and EBITDA of ₹1.1 Lakh (EBITDA margin 2.3%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. – 18 Bhola Baba Path, Sixmile, Gmc, Assam, India – 781022
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Fidrok Pharmaceuticals Private Limited
The main business activity of Fidrok Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fidrok Pharmaceuticals Private Limited FY 2025 filings available
Fidrok Pharmaceuticals Private Limited reported revenue of ₹47.05 Lakh (up 4605% YoY) for FY 2025.
Financial Statement Summary of Fidrok Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹1.1 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹77,674 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Fidrok Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | •••• |
| Net Profit Margin | 1.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fidrok Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Fidrok Pharmaceuticals Private Limited
Fidrok Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accurel Pharmaceuticals Private Limited | ₹47.27 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Mumbai, Maharashtra, India |
| Jivan Sambridhi Pharmaceuticals Private Limited | ₹47.25 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| KHK Pharmaceuticals Private Limited | ₹47.22 Lakh (FY 2023) | •••• | •••• | 183.0% | •••• | New Delhi, Delhi, India |
| Inverse Pharmaceuticals Private Limited | ₹47.09 Lakh (FY 2023) | •••• | •••• | 42.0% | •••• | Kanpur, Uttar Pradesh, India |
| Sulzderma Pharmaceuticals Private Limited | ₹47.07 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Nagpur, Maharashtra, India |
| Fidrok Pharmaceuticals Private Limited this company | ₹47.05 Lakh (FY 2025) | •••• | •••• | 4605.0% | •••• | Gmc, Assam, India |
| RDW Pharmaceuticals Private Limited | ₹47.05 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
| Alkyd Pharmaceuticals Private Limited | ₹47.01 Lakh (FY 2023) | •••• | •••• | -32.0% | •••• | Dhanbad, Jharkhand, India |
| Fineall Pharmaceuticals Private Limited | ₹47 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Ocuris Pharmaceuticals Private Limited | ₹46.98 Lakh (FY 2021) | •••• | •••• | 12.0% | •••• | Gurgaon, Haryana, India |
| Mother Land Pharmaceuticals Private Limited | ₹46.68 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Kumbakonam, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Fidrok Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Fidrok Pharmaceuticals Private Limited
Fidrok Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bondita Sarmah | Director | 13 May 2023 | 3 Years 5 Months | Current |
| Anannya Chakraborty | Director | 13 May 2023 | 3 Years 5 Months | Current |
| Chiranjib Bhuyan | Additional Director | 01 Jul 2025 | 1 Years 3 Months | Current |
Charges & Borrowings of Fidrok Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2025 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Fidrok Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Fidrok Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fidrok Pharmaceuticals Private Limited
Fidrok Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Chiranjib Bhuyan was appointed as Additional Director on 01 Jul 2025.
Credit Ratings, Litigation & Regulatory Alerts for Fidrok Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fidrok Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fidrok Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fidrok Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fidrok Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fidrok Pharmaceuticals Private Limited
Fidrok Pharmaceuticals is an active private limited company based in Gmc, Assam, India. It was incorporated on 13 May 2023 (3+ years old) and is registered under CIN U46497AS2023PTC024621.
Fidrok Pharmaceuticals reported revenue of ₹47.05 Lakh for FY 2025 (up 4605% YoY).
Fidrok Pharmaceuticals has 3 current directors:
- Bondita Sarmah - Director
- Anannya Chakraborty - Director
- Chiranjib Bhuyan - Additional Director
Fidrok Pharmaceuticals reported a net profit of ₹77,674 (net margin 1.7%) and EBITDA of ₹1.1 Lakh (EBITDA margin 2.3%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Fidrok Pharmaceuticals is U46497AS2023PTC024621. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fidrok Pharmaceuticals was incorporated on 13 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Fidrok Pharmaceuticals by revenue are Accurel Pharmaceuticals Private Limited, Jivan Sambridhi Pharmaceuticals Private Limited, KHK Pharmaceuticals Private Limited, Inverse Pharmaceuticals Private Limited, Sulzderma Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Chiranjib Bhuyan was appointed as Additional Director on 01 Jul 2025. Doly Baruah ceased to be Director on 01 Jul 2025. Anannya Chakraborty was appointed as Director on 13 May 2023. Fidrok Pharmaceuticals has 5 board changes on record in total.
The registered office of Fidrok Pharmaceuticals is at House No. – 18 Bhola Baba Path, Sixmile, Gmc, Assam, India – 781022.
Fidrok Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh.
No. Fidrok Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.